PT - JOURNAL ARTICLE AU - Di Guilmi, Julián AU - Salvo, Gloria AU - Mehran, Reza AU - Sood, Anil K. AU - Coleman, Robert L. AU - Lu, Karen H. AU - Vaporciyan, Ara AU - Ramirez, Pedro T. TI - Role of Video-Assisted Thoracoscopy in Advanced Ovarian Cancer: A Literature Review AID - 10.1097/IGC.0000000000000680 DP - 2016 May 01 TA - International Journal of Gynecologic Cancer PG - 801--806 VI - 26 IP - 4 4099 - http://ijgc.bmj.com/content/26/4/801.short 4100 - http://ijgc.bmj.com/content/26/4/801.full SO - Int J Gynecol Cancer2016 May 01; 26 AB - Abstract Tools that accurately predict the presence of metastatic ovarian cancer in the pleura are limited. Thus, we sought to summarize the current literature on video-assisted thoracoscopic surgery (VATS) and its applicability in patients with advanced ovarian cancer. A total of 187 patients with suspected ovarian cancer who underwent the VATS procedure were identified for this analysis. The median patient age was 59.4 years (range, 20.3–83 years). The median operative time for VATS was 32 minutes (range, 5–65 minutes). In 89 patients (48%), VATS revealed macroscopic disease in the pleural cavity. After VATS, 44 patients underwent neoadjuvant chemotherapy, and the remaining 143 patients underwent primary cytoreductive surgery. Video-assisted thoracoscopic surgery led to a change in disease stage or management in 76 patients (41%). Among patients with pleural effusions, VATS revealed pleural disease in 57% of patients, and 73% of patients with positive pleural cytology had evidence of pleural disease at the time of VATS. In addition, 23.5% of patients with negative pleural cytology had evidence of pleural disease at the time of VATS. Prospective trials are needed to accurately evaluate the impact of VATS on disease-free and overall survival in patients with advanced ovarian cancer. Video-assisted thoracoscopic surgery can help determine which patients are ideal candidates for surgical cytoreduction.